 Merck & Co. is getting out of the business of making Claritin allergy medicines and Coppertone sunscreens, selling off its over-the-counter business to Bayer AG for $14.2 billion.. Tuesday's deal is just the latest in a wave of mergers and acquisitions that is reshaping the global pharmaceutical industry. Many drug companies are narrowing their focus, dropping out of noncore businesses and bulking up where they have the size and expertise to generate significant sales growth.